The TranSmart foundation has added 13 new members to its board. Board members will serve one-year terms and meet quarterly.
Gold board members include Jamie Dananberg, the executive vice president of therapeutic areas at Takeda Pharmaceuticals; Brett Davis, general manager of ConvergeHealth by Deloitte and a principal at Deloitte Consulting; Matteo di Tomasso, the vice president of research business technology at Pfizer.
The list also includes Olivier Gien, global head for research and development health information technologies at Sanofi; Juergen Hammer, the global head for data science and center head of pharmaceutical research and early development informatics at Roche TCRC; and Jonathan Sheldon, global vice president of health sciences at Oracle.
The silver board members are Gilbert Omenn, a professor and director of the Center for Computational Medicine and Bioinformatics at the University of Michigan; Kenneth Pienta, a professor of urology at John Hopkins University hospital.
Bronze board members are James Burns, a professor in the department of microbiology and immunology at the Drexel University College of Medicine; and Lee Hood, the president of the Institute for Systems Biology.
Other board members are Hiroaki Kitano, the president of the Systems Biology Institute; Gerrit Meijer, the chair of the pathology department at VU University Medical Center in Amsterdam, and John Wilbanks, the chief commons officer of Sage Bionetworks.